Skip to main content

Table 2 Compared household use of different anti-malarial drugs from 2003 to 2015 of three study sites of western Kenya

From: Why some sites are responding better to anti-malarial interventions? A case study from western Kenya

Survey year Study site Type of anti-malarial drug used χ2 p value
(SP, AQ, CQ) (ACT, QN)
2015 Marani 6% (30/500) 94% (470/500) 27.54 0.0001
Kombewa 1.6% (8/500) 98.4% (492/500)
Iguhu 9.2% (46/500) 90.8% (454/500)
2010 Marani 31.9% (91/285) 68.1% (194/285) 50.48 0.0001
Kombewa 26.1% (52/199) 73.9% (147/199)
Iguhu 53.6% (185/345) 46.4% (160/345)
2007 Marani 30.1% (1145/3800) 69.9% (2655/3800) 119.45 0.0001
Kombewa 36.3% (340/937) 63.7% (597/937)
Iguhu 21% (984/4492) 79% (3508/4492)
2003 Marani 95.4% (207/217) 4.6% (10/217) 1.78 0.1821
Kombewa 93.9% (170/181) 6.1% (11/181)
Iguhu 96.2% (607/631) 3.8% (24/631)